Latest filing: Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Par Drugs and Chemicals Limited
ObservedCompany dossier
Par Drugs & Chemical
NSE:PAR · ISIN INE04LG01015
- Close
- ₹95.84 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Par Drugs & Chemical
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹21.4 Cr · PAT ₹0.6 Cr.
Exchange XBRLLatest ownership: promoter group 73.41% and public 26.59% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Par Drugs and Chemicals Limited
NSE · exchange filing
Observed
Source filing Trading Window - Par Drugs and Chemicals Limited
NSE · exchange filing
Observed
Source filing Action(s) taken or orders passed - Par Drugs and Chemicals Limited
NSE · exchange filing
Observed
Source filing Action(s) initiated or orders passed - Par Drugs and Chemicals Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹21.4 Cr
- Profit after tax
- ₹0.6 Cr
- EPS
- ₹0.47
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 73.41%
- Public
- 26.59%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL